Skip to content
Menu
Somnipeptide — homeSomnipeptide

An evidence review

RxSpan MD Review: Sermorelin ODT Introductory Price

RxSpan currently displays sermorelin ODT at $179 for the first month. Confirm renewal, injection availability, pharmacy and cancellation terms.

Published by Somnipeptide

Updated Editorial policy

Contents

The short version

RxSpan MD's current longevity catalog displays sermorelin ODT at $179 for the first month.9 This is an introductory oral-tablet quote. It does not establish the recurring price, current injection price or prescription-specific supply. The earlier full plan ladder was not reconfirmed as current offers.

We may earn a commission through our links; our disclosure explains that relationship. Compare the same formulation and payment period on our provider comparison.

Price and formulation

Ask for the renewal charge, selected term and total due before paying. A first-month price should not be compared directly against another provider's ongoing monthly charge. The current catalog view did not establish an injectable offer; that limitation does not prove an injection is unavailable. Confirm the formulation with the prescribing team.

Price and terms

Swipe to see all columns

PlanPublished figureWhat to confirm
Current catalogODT $179 first monthRecurring price and prescribed supply
InjectionCurrent quote not establishedAvailability, formulation and total
Confirm the same formulation, payment term and supply before comparing prices.

Oral-tablet and injection findings are not interchangeable. Our oral and sublingual guide discusses why each administration route needs evidence rather than assuming that avoiding needles preserves the same benefits.

Clinician, pharmacy and certification

RxSpan's previously documented FAQ names Belmar, Strive, Epiq Scripts and Casa Pharma Rx as pharmacy partners, and describes the Lion MD clinician network.1 Those are network disclosures, not proof of the clinician and pharmacy assigned to your prescription. Ask for both names and their state licenses.

The site displays a certification claim. We could not independently read its status from LegitScript's issuer checker. That does not establish that certification is absent or revoked; it means the badge is not independent verification for this comparison.

Terms to clarify

Confirm state eligibility, the payment period, cancellation cutoff and what happens if the clinician declines treatment. A product catalog does not establish which refund terms govern a particular prescription. Get the current order terms before choosing a prepaid option.

Our assessment

The current public quote is useful as an introductory ODT figure, but a purchase comparison needs its renewal price and prescribed supply. Ask whether an injectable formulation is offered if that is your preference, and discuss the evidence, potential side effects and monitoring with the prescriber. Our evidence review provides context without assuming a guaranteed sleep or recovery outcome.

Frequently asked questions

What does sermorelin cost at RxSpan MD?

Its current longevity catalog displays an ODT offer at $179 for the first month. Confirm renewal pricing, supply and any prepaid term. The earlier full ladder was not reconfirmed.

Is an injectable option available?

The current catalog view did not establish an injection offer or price. That does not prove unavailability. Ask the prescribing team about the current formulation options.

Is its certification independently verified?

The site displays a certification claim, but the issuer checker did not provide a readable status in this check. We do not treat the merchant badge alone as independent verification.

Notes & sources

  1. RxSpan MD (2026). Longevity treatment plans, pharmacy providers and medical team (homepage FAQ and plan selector). rxspanmd.com. https://www.rxspanmd.com/category/longevity
  2. Centers for Medicare & Medicaid Services (2026). NPPES NPI Registry (public search for National Provider Identifiers).. National Plan and Provider Enumeration System. https://npiregistry.cms.hhs.gov/
  3. U.S. Food and Drug Administration (2026). Warning Letters (searchable database of letters issued to regulated companies).. FDA Inspections, Compliance, Enforcement, and Criminal Investigations. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
  4. Ranke MB, Gruhler M, Rosskamp R, et al. (1986). Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.. European Journal of Pediatrics. https://pubmed.ncbi.nlm.nih.gov/2880720/
  5. Vittone J, Blackman MR, Busby-Whitehead J, et al. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.. Metabolism. https://pubmed.ncbi.nlm.nih.gov/9005976/
  6. Asano D, Takakusa H, Nakai D (2023). Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.. Pharmaceutics. https://pubmed.ncbi.nlm.nih.gov/38258058/
  7. Liu H, Bravata DM, Olkin I, et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly.. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/17227934/
  8. Quertermous J, Desai S, Harrison DJ (2018). The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.. Journal of Drugs in Dermatology. https://pubmed.ncbi.nlm.nih.gov/30005109/
  9. RxSpan MD (2026). Longevity — current first-month sermorelin ODT offer. RxSpan MD. https://www.rxspanmd.com/category/longevity

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Also in this collection